Growth Metrics

Alnylam Pharmaceuticals (ALNY) Construction in Progress (2017 - 2018)

Historic Construction in Progress for Alnylam Pharmaceuticals (ALNY) over the last 6 years, with Q4 2018 value amounting to $261.0 million.

  • Alnylam Pharmaceuticals' Construction in Progress rose 9527.48% to $261.0 million in Q4 2018 from the same period last year, while for Dec 2018 it was $261.0 million, marking a year-over-year increase of 9527.48%. This contributed to the annual value of $261.0 million for FY2018, which is 9527.48% up from last year.
  • As of Q4 2018, Alnylam Pharmaceuticals' Construction in Progress stood at $261.0 million, which was up 9527.48% from $133.6 million recorded in Q4 2017.
  • Alnylam Pharmaceuticals' 5-year Construction in Progress high stood at $261.0 million for Q4 2018, and its period low was $1.3 million during Q4 2015.
  • In the last 4 years, Alnylam Pharmaceuticals' Construction in Progress had a median value of $67.8 million in 2014 and averaged $99.5 million.
  • As far as peak fluctuations go, Alnylam Pharmaceuticals' Construction in Progress skyrocketed by 697857.14% in 2014, and later tumbled by 3516.65% in 2015.
  • Quarter analysis of 4 years shows Alnylam Pharmaceuticals' Construction in Progress stood at $2.0 million in 2014, then crashed by 35.17% to $1.3 million in 2015, then surged by 10300.39% to $133.6 million in 2017, then skyrocketed by 95.27% to $261.0 million in 2018.
  • Its Construction in Progress was $261.0 million in Q4 2018, compared to $133.6 million in Q4 2017 and $1.3 million in Q4 2015.